comprehens
understand
endocytosi
sapeloviru
psv
entri
cell
studi
psv
infect
context
cell
perturb
drug
inhibit
sirna
silenc
overexpress
domin
neg
dn
mutant
show
psv
infect
cell
unaffect
pretreat
chlorpromazin
eipa
knockdown
clathrin
heavi
chain
overexpress
dn
mutant
convers
psv
infect
sensit
nh
cl
chloroquin
dynasor
nystatin
wortmannin
reduc
psv
express
level
viru
titer
addit
psv
invas
lead
rapid
actin
rearrang
disrupt
cellular
actin
network
enhanc
psv
infect
intern
viru
transport
late
endosom
andor
cycl
endosom
requir
particip
find
demonstr
psv
use
caveolaedepend
endocytosi
predomin
entri
portal
cell
requir
low
ph
dynamin
sapeloviru
psv
formerli
porcin
sapeloviru
member
famili
picornavirida
sapeloviru
genu
like
picornavirida
psv
singl
strand
positivesens
nonenvelop
rna
viru
psv
genom
contain
singl
open
read
frame
consist
four
structur
protein
flank
nontransl
region
end
protein
locat
surfac
virion
expos
immun
system
exhibit
high
sequenc
variabl
sozzi
et
al
psv
readili
cultiv
pig
kidney
cell
includ
llcpk
lan
et
al
kim
et
al
among
cell
line
speci
two
psv
strain
found
replic
human
hepatocarcinoma
cell
line
green
monkey
kidney
cell
line
vero
pgmkc
bai
et
al
infect
psv
involv
wide
spectrum
symptom
rang
asymptomat
infect
clinic
symptom
includ
acut
diarrhea
polioencephalomyel
pneumonia
reproduct
disord
lan
et
al
arruda
et
al
past
decad
numer
outbreak
high
preval
occur
throughout
world
schock
et
al
son
et
al
arruda
et
al
caus
high
morbid
case
fatal
rate
usa
arruda
et
al
current
specif
treatment
psv
avail
although
monosaccharid
nacetylneuramin
acid
abil
block
viru
bind
infect
kim
et
al
addit
research
regard
mechan
psv
entri
infect
well
exposit
detail
studi
endocyt
mechan
involv
psv
uptak
urgent
need
virus
util
exist
cellular
endocyt
pathway
enter
infect
cell
endocyt
mechan
mainli
includ
clathrinmedi
endocytosi
cme
caveolardepend
endocytosi
macropinocytosi
phagocytosi
clathrinand
caveolinindepend
endocytosi
mercer
et
al
among
cme
major
endocyt
pathway
involv
cargo
select
vesicl
bud
mcmahon
boucrot
pathway
encompass
intern
virus
nutrient
growth
factor
receptor
tian
et
al
kawaguchi
et
al
cme
independ
lipid
raft
disrupt
actin
mean
restrain
phagocytosi
macropinocytosi
may
affect
pathway
merrifield
et
al
caveola
form
integr
membran
protein
known
caveolin
coat
complex
sever
caveolin
protein
ariotti
parton
associ
variou
cellular
function
includ
cell
signal
membran
tension
substrat
adhes
echarri
del
pozo
sohn
et
al
caveolaedepend
endocytosi
report
implic
host
cell
entri
japanes
enceph
viru
canin
respiratori
coronaviru
szczepanski
et
al
pest
de
petit
rumin
viru
yang
et
al
dynam
endocyt
pathway
tightli
regul
rab
gtpase
involv
compartment
endocyt
pathway
earli
recycl
late
lysosom
rout
wanding
zerial
rab
protein
report
implic
life
cycl
mani
viru
includ
japanes
enceph
viru
liu
et
al
classic
swine
fever
viru
shi
et
al
porcin
hemagglutin
encephalomyel
viru
howev
mechan
rab
protein
requir
psv
infect
still
remain
poorli
understood
work
provid
evid
psv
entri
cell
follow
caveolaeand
dynamindepend
clathrinindepend
pathway
moreov
show
psv
entri
depend
independ
requir
lowph
manner
find
indic
psvmediat
endocytosi
occur
within
lateendosom
compart
addit
show
psv
replic
depend
actin
organ
accordingli
inhibit
actin
polymer
cell
lead
increas
psv
replic
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
gibco
usa
iuml
penicillin
streptomycin
psv
csh
strain
isol
diarrheal
pig
preserv
laboratori
lan
et
al
plasmid
express
gfptag
wildtyp
wt
domin
neg
dn
mutant
wt
dn
mutant
wt
dn
mutant
wt
dn
mutant
rab
wt
dn
mutant
rab
wt
dn
mutant
rab
wt
dn
mutant
rab
construct
laboratori
sequenc
sangon
shanghai
china
endocyt
inhibitor
includ
chlorpromazin
cpz
ammonium
chlorid
nh
cl
chloroquin
cq
nystatin
dynasor
nethylnisopropyl
amilorid
eipa
cytochalasin
cytod
jasplakinolid
jasp
purchas
sigma
alexa
fluor
cholera
toxin
b
ctb
alexa
fluor
transferrin
tfn
alexa
alexa
fluor
goat
antimous
secondari
antibodi
purchas
invitrogen
carlsbad
ca
unit
state
mous
polyclon
antipsv
antibodi
gener
laboratori
cell
seed
plate
densiti
cellswel
grown
h
treat
pharmacolog
inhibitor
indic
concentr
h
two
wash
dpb
cell
count
solut
ad
dmem
contain
fb
well
incub
h
absorb
nm
measur
micropl
reader
confluent
monolay
cell
grown
plate
pretreat
appropri
concentr
inhibitor
h
cell
expos
psv
moi
h
cell
lysat
collect
tcid
western
blot
analysi
detect
viru
intern
cell
pretreat
subtox
dose
inhibitor
h
inocul
psv
h
viru
bind
cell
wash
icecold
pb
three
time
complet
remov
unbound
virus
shift
h
allow
intern
cell
lyse
subject
rtqpcr
analysi
sirna
oligo
target
su
scrofa
clathrin
heavi
chain
sichc
rab
rab
ucuc
rab
rab
neg
control
sinc
purchas
genepharma
biotech
shanghai
china
cell
transfect
appropri
sirna
use
lipofectamin
transfect
reagent
beyotim
biotechnolog
shanghai
china
accord
manufactur
instruct
transfect
h
cell
lyse
total
rna
extract
use
trizol
invitrogen
knockdown
effici
quantifi
rtqpcr
data
present
triplic
sampl
express
wt
dn
mutant
form
plasmid
also
transfect
cell
use
lipofectamin
h
post
transfect
cell
infect
psv
moi
h
cell
sampl
dissoci
ripa
buffer
contain
pmsf
proteas
inhibitor
cocktail
heat
min
electrophores
polyacrylamid
gel
protein
transfer
onto
pvdf
membran
biorad
hercul
ca
membran
block
nonfat
milk
h
room
temperatur
membran
incub
overnight
mous
polyclon
antibodi
h
room
temperatur
rabbit
monoclon
antibodi
wash
time
antimous
antirabbit
secondari
antibodi
conjug
hrp
use
band
develop
ecl
prime
western
blot
detect
reagent
ge
healthcar
quantifi
imag
proplu
softwar
viru
titrat
detect
inhibitor
treat
mocktreat
cell
infect
psv
collect
freez
thaw
three
time
centrifug
remov
cell
debri
serial
dilut
collect
viru
ad
plate
co
day
cytopath
effect
cpe
record
viru
titer
calcul
use
reedmuench
method
record
tcid
cell
first
pretreat
nh
cl
cq
differ
concentr
infect
psv
h
coloc
caveolin
cell
transfect
egfptag
caveolin
infect
viru
cell
fix
paraformaldehyd
permeabil
triton
min
block
bovin
serum
albumin
bsa
h
room
temperatur
incub
mous
polyclon
antibodi
overnight
alexa
fluor
conjug
goat
antimous
igg
antibodi
h
room
temperatur
cell
nuclei
final
stain
dapi
observ
fluoresc
microscopi
actin
rearrang
analysi
monolay
incub
alexa
fluor
min
incub
polyclon
antibodi
alexa
fluor
conjug
goat
antimous
igg
antibodi
final
cell
incub
ml
dapi
min
observ
confoc
microscopi
clsm
leica
germani
alexa
fluor
tfn
alexa
fluor
ctb
molecular
probe
use
uptak
assay
briefli
cell
seed
plate
treat
differ
inhibitor
h
cell
incub
tfn
ctxb
min
cell
nuclei
stain
dapi
cell
observ
confoc
microscopi
data
present
mean
sd
least
three
independ
experi
statist
analys
perform
use
twotail
student
ttest
oneway
analysi
varianc
tukey
posthoc
graphpad
prism
p
consid
statist
signific
inhibitor
specif
block
differ
entri
pathway
use
investig
earli
step
psv
infect
cell
therefor
cell
viabil
upon
drug
treatment
determin
use
kit
result
reveal
absorb
inhibitor
nh
cl
mm
cq
cpz
nystatin
mm
dynasor
eipa
cytod
jasp
wortmannin
signific
differ
control
fig
order
detect
whether
psv
ph
depend
cell
pretreat
weakli
basic
amin
nh
cl
cellular
endosom
acidif
inhibitor
cq
select
rais
lumin
ph
cell
infect
psv
presenc
either
mm
nh
cl
cq
psv
intern
decreas
less
level
compar
untreat
cell
fig
similarli
reagent
inhibit
viral
protein
synthesi
inhibitor
pretreat
post
treat
fig
furthermor
viru
titer
assay
perform
cell
treat
nh
cl
cq
h
psv
inocul
reveal
cellular
endosom
acidif
also
signific
effect
psv
entri
cell
nh
cl
cq
dosedepend
decreas
viru
entri
replic
fig
examin
valid
ph
depend
psv
infect
ifa
perform
rel
infect
rate
psv
monitor
ifa
also
inhibit
differ
concentr
nh
cl
cq
fig
altogeth
find
indic
psv
use
phdepend
like
endosom
cell
entri
pathway
assess
role
clathrindepend
endocytosi
psv
entri
cell
select
cpz
wide
use
block
clathrin
mediat
endocytosi
prevent
assembl
clathrinco
pit
plasma
membran
wang
et
al
uptak
assay
first
demonstr
tfn
uptak
effect
inhibit
cpz
fig
effect
cpz
psv
entri
detect
western
blot
unexpectedli
obviou
differ
psv
synthesi
found
cell
treat
cpz
viru
infect
compar
untreat
control
cell
fig
next
examin
effect
cpz
viru
intern
viru
titer
found
treatment
cell
differ
concentr
cpz
affect
viru
progeni
product
viru
intern
fig
signific
differ
found
viru
titer
cell
treat
cpz
untreat
cell
differ
approach
investig
effect
silenc
express
chc
psv
uptak
infect
first
cell
transfect
sirna
neg
control
sirna
target
chc
h
infect
psv
h
found
sichc
could
specif
decreas
rna
copi
chc
fig
wherea
signific
facilit
psv
synthesi
observ
fig
function
wt
dn
construct
confirm
cell
use
label
transferrin
control
shi
et
al
examin
psv
infect
cell
overexpress
wt
dn
construct
effect
observ
psv
product
construct
fig
collect
result
indic
psv
capabl
enter
infect
cell
lack
function
cme
pathway
caveolaemedi
endocytosi
requir
integr
lipid
raft
cholesterol
deplet
plasma
membran
render
caveola
flatten
thereto
cholesterol
promin
compon
lajoi
nabi
sequestr
membran
cholesterol
nystatin
deplet
cholesterol
could
inhibit
caveolaemedi
endocytosi
smart
anderson
ctxb
uptak
block
nystatin
mm
pretreat
cell
fig
cell
mocktreat
pretreat
nystatin
differ
concentr
h
infect
psv
moi
presenc
drug
inhibitor
post
treat
viru
ad
h
h
postinfect
cell
process
western
blot
result
indic
viru
protein
synthesi
significantli
decreas
pretreat
nystatin
pretreat
nystatin
post
treat
nystatin
fig
signific
reduct
viral
rna
observ
inhibitor
treat
cell
compar
mock
treat
cell
fig
addit
data
obtain
viru
titer
assay
reveal
viru
titer
cell
pretreat
nystatin
nystatin
significantli
lower
compar
mocktreat
cell
fig
nearli
ident
result
acquir
altern
assay
use
place
nystatin
contrast
mocktreat
cell
protein
synthesi
progeni
viru
product
significantli
decreas
cell
pretreat
post
treat
mm
mm
dosedepend
manner
fig
verifi
result
detect
role
caveola
viral
infect
given
indispens
format
stabil
caveola
small
interf
rna
target
use
investig
function
caveola
viru
entri
effici
knockdown
first
valid
qpcr
fig
cell
transfect
sinc
follow
psv
entri
assay
expect
reduct
express
rna
interfer
could
significantli
decreas
protein
synthesi
compar
mocktreat
cell
fig
addit
function
wt
dn
construct
valid
cell
shi
et
al
expect
significantli
decreas
protein
express
level
observ
dn
constructtransfect
cell
compar
vector
wt
constructtransfect
cell
fig
also
found
virion
coloc
caveolin
incub
fig
larg
gtpase
dynamin
essenti
endocytosi
includ
caveolaemedi
clathrinmedi
endocytosi
clathrinand
caveolaeindepend
endocytosi
pathway
huang
et
al
vermaak
et
al
tfn
uptak
assay
show
dynasor
could
effect
inhibit
intern
tfn
cell
fig
investig
whether
dynamin
involv
psv
entri
infect
effect
dynasor
gtpase
inhibitor
target
macia
et
al
test
use
western
blot
viru
titer
assay
data
obtain
western
blot
suggest
viru
protein
synthesi
significantli
affect
cell
pretreat
differ
concentr
dynasor
fig
howev
obviou
effect
protein
express
found
post
treat
dynasor
mocktreat
cell
next
examin
effect
differ
concentr
dynasor
viru
titer
viru
intern
result
indic
pretreat
cell
dynasor
significantli
decreas
psv
titer
viral
rna
copi
number
fig
examin
valid
dynamin
depend
psv
infect
cell
transfect
plasmid
express
either
wt
dn
form
h
posttransfect
cell
infect
psv
moi
h
protein
synthesi
analyz
use
western
blot
fig
expect
protein
synthesi
significantli
decreas
dynamin
dn
overexpress
cell
altogeth
find
indic
cell
entri
psv
cell
depend
dynamin
psv
entri
depend
macropinocytosi
requir
clinic
inhibitor
na
h
exchang
eipa
play
import
role
macropinocytosi
format
koivusalo
et
al
wortmannin
coval
inhibitor
phosphatidylinositol
involv
multipl
stage
macropinocytosi
mercer
heleniu
therefor
use
eipa
wortmannin
clarifi
role
macropinocytosi
psv
entri
infect
pretreat
cell
differ
concentr
eipa
result
variat
psv
protein
synthesi
viru
titer
viral
rna
copi
number
compar
mocktreat
cell
fig
c
howev
wortmannin
treatment
obvious
reduc
psv
protein
express
level
fig
expect
wortmannin
could
significantli
affect
viral
titer
viral
intern
fig
demonstr
macropinocytosi
may
essenti
viru
entri
infect
psv
entri
requir
activ
previou
research
found
factin
crosslink
protein
filamin
essenti
caveolaedepend
transcytosi
albumin
sverdlov
et
al
furthermor
regul
actin
polymer
well
remodel
plasma
membran
could
regul
caveola
endocytosi
klein
et
al
test
whether
psv
util
actindriven
transport
entri
cell
cell
mocktreat
infect
psv
actin
examin
use
phalloidin
stain
mocktreat
cell
actin
stress
fiber
arrang
order
visibl
virustr
cell
actin
cytoskeleton
depolymer
found
follow
decreas
actin
stress
fiber
transient
bleb
cell
surfac
fig
demonstr
activ
role
actin
network
psv
replic
use
actinspecif
inhibitor
cytochalasin
cyto
block
polymer
new
actin
filament
taylor
et
al
jasplakinolid
jasp
reduc
actin
dynam
identifi
disrupt
actin
filament
cyto
led
increas
protein
synthesi
fig
similarli
jasp
result
increas
protein
synthesi
fig
addit
treatment
cell
cyto
express
psv
quantifi
normal
rel
mocktreat
group
set
error
bar
indic
standard
deviat
triplic
sampl
two
independ
experi
c
viru
titer
sampl
collect
h
postinfect
cell
infect
psv
moi
presenc
nh
cl
cq
data
mean
sd
two
independ
experi
cell
mocktreat
pretreat
nh
cl
cq
h
subsequ
infect
psv
h
follow
fix
permeabil
stain
antipsv
primari
antibodi
scale
bar
p
p
versu
mocktreat
group
jasp
significantli
increas
psv
titer
compar
mocktreat
cell
fig
e
togeth
result
indic
inhibit
actin
filament
polymer
need
dynam
actin
remodel
cell
could
stimul
psv
replic
rab
protein
known
regul
membran
traffic
involv
format
transport
vesicl
donor
membran
fusion
target
membran
hutagalung
novick
therefor
examin
effect
rnaimedi
knockdown
rab
protein
psv
infect
western
blot
viru
titer
assay
effici
knockdown
first
valid
qpcr
fig
western
blot
show
deplet
reduc
protein
express
level
respect
compar
sinctransfect
cell
fig
complementari
approach
viral
titer
assay
indic
viru
titer
cell
treat
significantli
lower
compar
sinctransfect
cell
fig
explor
role
rab
protein
psv
infect
cell
transfect
plasmid
express
egfptag
wt
dn
wt
dn
wt
dn
wt
dn
h
posttransfect
cell
infect
psv
moi
h
later
viru
protein
express
level
detect
western
blot
overexpress
dn
dn
reduc
protein
synthesi
respect
fig
howev
signific
alter
protein
level
observ
follow
overexpress
egfptag
dn
plasmid
compar
control
cell
express
plasmid
indic
psv
use
pathway
earli
endosom
need
late
endosomeslysosom
recycl
endosom
infect
cell
endocyt
entri
virus
occur
stepwis
manner
involv
cell
adhes
receptor
cluster
signal
activ
format
endocyt
vesicl
deliveri
viral
cargo
endosom
compart
escap
cytosol
cossart
heleniu
mani
virus
shown
util
endocyt
pathway
promot
viru
entri
host
cell
regul
endocytosi
pleiotrop
cell
type
depend
virus
actual
could
use
one
endocyt
pathway
entri
cell
cossart
heleniu
detail
research
viru
entri
fundament
contribut
develop
novel
antivir
therapi
block
viru
intern
host
cell
studi
analyz
major
endocyt
pathway
combin
distinct
independ
approach
pharmacolog
inhibitor
first
use
inhibit
correspond
pathway
specif
assess
use
highli
specif
dn
mutant
plasmid
sirna
knockdown
verifi
result
among
endocyt
pathway
taken
virus
cme
commonli
use
clathrin
transport
larg
varieti
differ
cargo
plasma
membran
respons
receptormedi
endocytosi
signal
compos
clathrin
light
chain
clathrin
heavi
chain
halebian
et
al
clathrinmedi
endocytosi
vesicl
scission
acceler
larg
gtpase
dynamin
involv
dynam
function
neck
clathrinco
pit
ferguson
et
al
result
indic
transfect
sirna
target
chc
reduc
clathrin
express
cell
without
affect
psv
infect
furthermor
dn
mutant
dynamin
dn
mutant
inhibit
psv
express
viru
titer
suggest
psv
enter
cell
cme
dynaminindepend
endocytosi
caveolaemedi
endocytosi
character
presenc
caveolin
scaffold
protein
import
protein
compon
caveola
involv
cholesterol
traffick
signal
transduct
endocytosi
schlegel
lisanti
fig
psv
depend
clathrinmedi
endocytosi
cme
cme
inhibitor
chlorpromazin
cpz
block
transferrin
entri
cell
pretreat
cpz
h
incub
alexa
fluor
transferrin
min
incub
cell
fix
analyz
confoc
microscop
bar
b
effect
pretreat
cell
increas
concentr
cpz
cpz
post
treat
viru
ad
h
determin
western
blot
use
antipsv
primari
antibodi
c
cpz
inhibit
psv
infect
cell
pretreat
increas
concentr
cpz
h
cell
infect
psv
h
cell
lyse
quantit
viral
rna
copi
number
rtqpcr
cell
lyse
viru
titer
detect
hpi
cell
transfect
sirna
neg
control
sinc
sirna
target
clathrin
heavi
chain
chc
h
rna
copi
chc
assess
qrtpcr
detect
sirna
effici
chc
e
clathrin
knockdown
nt
inhibit
psv
replic
sinc
sichctransfect
cell
infect
psv
h
viral
protein
level
determin
western
blot
f
cell
transfect
construct
encod
gfptag
wildtyp
wt
domin
neg
dn
mutant
vector
h
follow
infect
psv
viral
protein
synthesi
level
estim
western
blot
data
present
mean
sd
least
two
independ
experi
p
p
compar
mocktreat
cell
parton
simon
importantli
specif
bind
cholesterol
induc
caveola
format
drab
et
al
yang
et
al
intracellular
accumul
cholesterol
facilit
express
transfect
stimul
cholesterol
synthesi
field
et
al
field
et
al
similarli
murin
cell
caveola
format
abrog
drab
et
al
data
demonstr
cholesterol
deplet
suppress
psv
infect
impli
import
fluiditi
cholesterol
psv
entri
replic
togeth
evid
knockdown
overexpress
dn
mutant
also
inhibit
psv
prolifer
find
indic
psv
use
caveolaemedi
endocytosi
like
alter
integr
membran
lipid
initi
product
infect
macropinocytosi
transient
actindepend
cellular
process
normal
involv
fluid
uptak
usual
macropinocytosi
featur
actin
microfilamentmedi
cell
plasma
membran
ruffl
bleb
activ
mercer
heleniu
observ
typic
inhibitor
macropinocytosi
eipa
influenc
psv
infect
effect
measur
psv
express
level
viru
titer
disrupt
cellular
actin
network
exposur
pharmacolog
inhibitor
cytod
jasp
psv
infect
unperturb
strongli
enhanc
cytod
jasp
disrupt
dynam
function
actin
network
cytod
latrunculinb
lead
increas
tomato
bushi
stunt
viru
replic
infect
cell
nawazulrehman
et
al
mechan
tomato
bushi
stunt
viru
regul
function
cofilin
lead
inhibit
dynam
function
actin
network
induc
viru
util
exist
actin
filament
effici
recruit
host
protein
lipid
viral
replic
nawazulrehman
et
al
howev
specif
mechan
inhibit
actin
filament
polymer
stimul
psv
replic
whether
due
dynam
actin
remodel
cell
unclear
thu
studi
still
need
clarifi
rab
gtpase
function
involv
endocyt
traffick
notabl
among
endocyt
rab
gtpase
function
format
clathrinco
vesicl
clathrinco
vesicl
fusion
earli
endosom
homotyp
fusion
earli
endosom
bucci
et
al
mclauchlan
et
al
act
downstream
regul
transport
earli
late
endosom
lysosom
vitelli
et
al
jager
et
al
regul
endosom
transgolgi
network
transport
lombardi
et
al
control
transport
along
recycl
pathway
earli
recycl
endosom
cell
surfac
ullrich
et
al
previou
studi
demonstr
bluetongu
viru
util
late
endosomespecif
lipid
factor
lysobisphosphatid
acid
viral
entri
earli
endosom
patel
et
al
fig
infect
cell
psv
inhibit
disrupt
caveolaeraftdepend
endocyt
mechan
inhibit
ctb
uptak
cell
determin
nystatin
pretreat
cell
nystatin
mm
result
nearcomplet
blockad
ctb
uptak
bar
b
cell
mocktreat
pretreat
differ
concentr
nystatin
follow
infect
psv
moi
continu
presenc
drug
inhibitor
post
treat
viru
ad
h
h
postinfect
cell
process
western
blot
level
viru
protein
synthesi
detect
use
antibodi
quantif
band
correspond
correct
normal
mocktreat
cell
set
c
pretreat
preconcert
inhibitor
cell
infect
psv
h
h
infect
cell
lyse
determin
viral
rna
copi
number
rtqpcr
viru
titer
determin
tcid
sampl
prepar
h
postinfect
cell
infect
psv
presenc
differ
concentr
nystatin
e
silenc
effici
determin
qrtpcr
use
method
f
cell
transfect
sirna
neg
control
sinc
h
infect
psv
moi
h
viru
propag
viral
protein
synthesi
level
estim
western
blot
g
effect
wildtyp
caveolin
wt
domin
neg
mutant
caveolin
dn
psv
infect
determin
western
blot
data
present
mean
sd
least
two
independ
experi
p
p
compar
mocktreat
cell
h
psv
particl
coloc
caveolin
cell
transfect
egfptag
caveolin
incub
psv
enlarg
box
indic
psv
red
swallow
vesicl
structur
bear
caveolin
green
outer
surfac
coloc
signal
wide
observ
use
confoc
microscopi
studi
effect
rab
protein
viru
entri
detect
found
transfect
sirna
express
dn
mutant
could
decreas
psv
express
level
express
dn
dn
construct
effect
viral
infect
specul
activ
function
late
endocyt
pathway
recycl
pathway
requir
effect
psv
infect
conclus
result
provid
evid
psv
cell
entri
follow
caveolaemedi
pathway
requir
fluiditi
cholesterol
independ
clathrin
dynamin
macropinocytosi
fig
psv
enter
cell
occur
dynamindepend
manner
cell
pretreat
dynasor
h
incub
alexa
fluor
transferrin
min
cell
fix
analyz
confoc
microscop
bar
b
cell
mocktreat
pretreat
dynasor
h
infect
psv
moi
dynasor
post
treat
viru
ad
h
indic
time
cell
process
western
blot
quantif
band
correspond
correct
data
normal
valu
mocktreat
cell
c
similar
cell
treat
differ
concentr
drug
infect
psv
cell
lysat
collect
viru
titer
viral
rna
copi
number
determin
effect
wildtyp
dynamin
dyn
wt
domin
neg
mutant
dynamin
dyn
dn
psv
infect
determin
western
blot
describ
data
present
mean
sd
least
two
independ
experi
p
p
compar
mocktreat
cell
psv
entri
inhibit
drug
affect
macropinocytosismedi
endocytosi
requir
b
immunoblot
cell
infect
psv
treat
differ
concentr
amilorid
eipa
wortmannin
use
antibodi
quantif
band
correspond
correct
data
normal
valu
mocktreat
cell
c
similar
cell
treat
differ
concentr
eipa
wortmannin
subsequ
infect
psv
incub
h
cell
lysat
collect
viru
titer
determin
cell
infect
psv
h
h
cell
collect
rtqpcr
data
mean
sd
least
two
independ
experi
p
p
compar
mocktreat
cell
dynam
actin
network
addit
conduct
psv
traffic
late
endosom
andor
recycl
endosom
process
requir
particip
activ
exposur
low
ph
upon
fusion
viral
cellular
membran
within
late
endosom
mechan
viru
ribonucleoprotein
complex
releas
transport
nucleu
remain
determin
fig
psv
enter
cell
lead
activ
actin
rearrang
cell
mocktreat
infect
psv
moi
min
fix
stain
actin
alexa
fluor
red
min
follow
stain
antibodi
alexa
goat
antimous
secondari
antibodi
green
dapi
blue
bar
b
c
effect
actin
inhibitor
cytochalasin
cytod
jasplakinolid
jasp
viru
protein
express
detect
western
blot
analysi
e
effect
pretreat
cell
increas
concentr
cytod
jasp
psv
particl
yield
detect
viru
titer
assay
data
mean
sd
least
two
independ
experi
p
p
compar
mocktreat
cell
silenc
effici
sirab
determin
qrtpcr
use
method
b
c
cell
pretransfect
sirna
neg
control
sinc
h
infect
psv
incub
h
psv
express
level
protein
viru
titer
determin
western
blot
tcid
respect
effect
wildtyp
dynamin
wt
domin
neg
dn
mutant
psv
infect
determin
western
blot
describ
result
present
mean
sd
three
independ
experi
p
p
compar
mocktreat
cell
